Clinical Cases in GIST: Adherence to the ESMO Clinical Practice Guidelines

Clinical Cases in GIST

 

 

As part of ESMO's continuous commitment to offering beneficial educational material relevant to your work and practice in order to receive your certificate, please complete the Evaluation Survey, which will take approximately 5 minutes. Please indicate which rating reflects your answer.

Questions marked with are required.

1. Did your undertaking of this E-Learning module provide an update on the role of adjuvant therapy for localised, resectable GIST, considering the risk stratification, histological staining and mutational analyses? (1-not at all; 5-a lot)

2. Did your undertaking of this E-Learning module provide an update on the role of molecularly targeted therapy for patients with metastatic GIST, response evaluation, and follow-up? (1-not at all; 5-a lot)

3. Did your undertaking of this E-Learning module provide information regarding an evidence-based treatment algorithm for patients with imatinib-resistant GIST, considering the implications of mutational transformation on therapeutic choice? (1-not at all; 5-a lot)

4. Did your undertaking of this E-Learning module provide information regarding an evidence-based treatment algorithm for patients with imatinib-resistant GIST, considering the implications of mutational transformation on therapeutic choice (1-not at all; 5-a lot)

5. How would you rate the interactivity level offered in the E-Learning material? (1-poor; 5-excellent)

6. Was the information useful and relevant to your work and practice? (1-not at all; 5-completely)

7. Do you feel that the information presented was well balanced and supported by adequate evidence? (1-not at all; 5-absolutely)

8. If you would like to add your personal comments or make suggestions to improve future ESMO E-Learning material, please write in the box below: